Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2018, Article ID 7925019, 3 pages
https://doi.org/10.1155/2018/7925019
Case Report

Successful Treatment of Acromegaly and Associated Hypogonadism with First-Line Clomiphene Therapy

1Diabetes & Endocrinology Institute at Renaissance, Edinburg, TX 78539, USA
2Division of Neurosurgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA
3Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA

Correspondence should be addressed to Atil Y. Kargi; ude.imaim.dem@igraka

Received 27 February 2018; Accepted 23 May 2018; Published 26 June 2018

Academic Editor: John Broom

Copyright © 2018 Juan D. Palacios et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Katznelson, D. Kleinberg, and M. L. Vance, “Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study,” Clinical Endocrinology, vol. 54, no. 2, pp. 183–188, 2001. View at Publisher · View at Google Scholar
  2. L. Katznelson, E. R. Laws Jr., S. Melmed et al., “Acromegaly: an endocrine society clinical practice guideline,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 11, pp. 3933–3951, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. F. H. Duarte, R. S. Jallad, and M. D. Bronstein, “Clomiphene citrate for treatment of acromegaly not controlled by conventional therapies,” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 5, pp. 1863–1869, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho, “Estrogen regulation of growth hormone action,” Endocrine Reviews, vol. 25, no. 5, pp. 693–721, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Vallette and O. Serri, “Oral estroprogestin: An alternative low cost therapy for women with postoperative persistent acromegaly?” The Pituitary Society, vol. 13, no. 4, pp. 311–314, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. E. V. Dimaraki, K. V. Symons, and A. L. Barkan, “Raloxifene decreases serum IGF-I in male patients with active acromegaly,” European Journal of Endocrinology, vol. 150, no. 4, pp. 481–487, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Attanasio, M. Barausse, and R. Cozzi, “Raloxifene lowers IGF-I levels in acromegalic women,” European Journal of Endocrinology, vol. 148, no. 4, pp. 443–448, 2003. View at Publisher · View at Google Scholar · View at Scopus